SARS-CoV-2 Genetic Diversity and Evolution

Like other coronaviruses, SARS-CoV-2 is evolving. The genomic diversity of SARS-CoV-2 strains in different countries is consistent with multiple introductions of the virus to different locations, seeding local transmission events. The papers in this feed report latest research into genetic variation and phylogeny of this highly successful virus.

August 1, 2020

Roles of flavonoids against coronavirus infection

Chemico-biological Interactions
Maria RussoGian Luigi Russo
July 28, 2020
Open Access

Evolution of viral quasispecies during SARS-CoV-2 infection

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
A JaryD Boutolleau
July 30, 2020
Open Access

Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic

Nature Microbiology
Maciej F BoniDavid L Robertson
July 31, 2020

Phylogenomic analysis of SARS-CoV-2 genomes from western India reveals unique linked mutations

BioRxiv : the Preprint Server for Biology
D. PaulYogesh S Shouche
July 31, 2020

New Pathways of Mutational Change in SARS-CoV-2 Proteomes Involve Regions of Intrinsic Disorder Important for Virus Replication and Release

BioRxiv : the Preprint Server for Biology
T. TomaszewskiGustavo Caetano-Anolles
July 24, 2020
Open Access

Geographic reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase

MedRxiv : the Preprint Server for Health Sciences
V. MicheliVirology and Diagnostic of Bioemergencies Group Laboratory of Clinical Microbiology
July 24, 2020
Open Access

Single-nucleotide conservation state annotation of SARS-CoV-2 genome

BioRxiv : the Preprint Server for Biology
Soo Bin Kwon, Jason Ernst
July 24, 2020

Emergence of European and North American mutant variants of SARS-CoV-2 in Southeast Asia

Transboundary and Emerging Diseases
Ovinu Kibria IslamM Anwar Hossain
July 23, 2020

Mathematical modelling on phase based transmissibility of Coronavirus

Infectious Disease Modelling
M Veera Krishna, J Prakash
August 2, 2020

A palindromic RNA sequence as a common breakpoint contributor to copy-choice recombination in SARS-COV-2

Archives of Virology
William R Gallaher
July 30, 2020

The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing

Emerging Microbes & Infections
Joilson XavierMarluce Aparecida Assunção Oliveira
July 27, 2020
Open Access

Evolution and epidemic spread of SARS-CoV-2 in Brazil

Darlan S CandidoNuno Rodrigues Faria
August 4, 2020
Open Access

Understanding genomic diversity, pan-genome, and evolution of SARS-CoV-2

Arohi ParlikarGaurav Sharma
July 24, 2020
Open Access

Point-of-Use Rapid Detection of SARS-CoV-2: Nanotechnology-Enabled Solutions for the COVID-19 Pandemic

International Journal of Molecular Sciences
Navid RabieeRajender S Varma
July 28, 2020
Open Access

The mutational analysis unveils the distribution of G614 genotype of SARS-CoV-2in different Indian states and its association with case fatality rate of COVID-19

BioRxiv : the Preprint Server for Biology
Ballamoole Krishna KumarI. Karunasagar
August 4, 2020

Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2

Infectious Diseases of Poverty
Hong-Zhi ChenXiang Wu

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

© 2020 Meta ULC. All rights reserved